NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Serologic Surveillance for SARS-CoV-2 (COVID-19) in a Prospective Cohort of Health Care Workers

UnknownN/A

Sponsor: Hospital Italiano de Buenos Aires

Conditions: COVID-19, SARS-CoV 2, Health Personnel

Interventions: Serologic SARS-CoV-2 screening

The investigators will follow a single prospective cohort of 50 Health Care Workers in the Hospital Italiano de Buenos Aires (Argentina) from May 15th to August 31st 2020 using antibody testing for SARS-CoV-2 IgM and IgG at baseline and every 2 weeks in order to assess the incidence of COVID-19, the prevalence of anti-SARS-CoV-2 antibodies (IgM and IgG) and incidence of reinfection or reactivations of previous COVID-19 using viral gene sequencing in this cohort.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: Yes

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

1. Healthcare staff (Physicians) AND
2. Directly involved in care of patients with confirmed or suspected COVID-19 AND
3. Working in any of the two hospital venues (Hospital Italiano Central and Hospital Italiano San Justo Agustín Rocca).

Exclusion Criteria:

1. Refusal to sign the Informed Consent Form OR
2. Experienced symptoms compatible with COVID-19 in the last 14 days prior to eligibility screening